Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
More articles by Brian Boettcher Proposal for a Tirzepatide-LLF580 Fusion Protein Apr 16, 2023 Proposal for a Tirzepatide-LLF580 Fusion Protein A new proposal published on ResearchGate is an extension of my prior article (Boettcher, 2023) updating the gastric Gastric Bypass Surgery Mimetic Update Mar 21, 2023 Gastric Bypass Surgery Mimetic Update Fc-FGF21 fusion protein analog with an additional stabilizing disulfide linkage may be suitable for once a month dosing in humans Feb 21, 2020 Fc-FGF21 fusion protein analog with an additional stabilizing disulfide linkage may be suitable for once a month dosing in humans A new patent application (Goldfine and Yi 2019) provides pharmacokinetic data from cynomolgus monkeys that may support Pancreatitis is an FGF21-deficient state that is corrected by replacement therapy Jan 11, 2020 Pancreatitis is an FGF21-deficient state that is corrected by replacement therapy A new report in Science Translational Medicine (January 8, 2020) from the David Mangelsdorf and Steven Kliewer lab Novartis to Initiate Phase 3 Clinical Trial with TQJ230 Targeting Lipoprotein(a) Dec 6, 2019 Novartis to Initiate Phase 3 Clinical Trial with TQJ230 Targeting Lipoprotein(a) The first project that I helped initiate at a Novartis precursor company (Sandoz) over 25 years ago targeted Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity Sep 5, 2019 Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity A new report published in the Journal of the American Medical Association indicates that metabolic surgeries (mainly Six Approaches to Mimic Gastric Bypass Surgery Sep 17, 2018 Six Approaches to Mimic Gastric Bypass Surgery For details on these approaches see Boettcher, B
In the U.S., GLP-1 prescriptions more than doubled in just 18 months, topping nine million by early 2024
Projected settlement range examples from comparable GLP-1 litigation: $50,000 to $100,000 for cases with relatively limited documented harm $100,000 to $300,000 for significant medical treatment and extended care $300,000 to $500,000 for serious, enduring injuries with substantial costs $500,000 to $700,000+ for severe or permanently disabling conditions These projections are estimates, not guarantees, and actual outcomes for Victoza injury claims will vary based on individual case details
$12.25 L-Carnitine is a non-essential amino acid that helps to maintain overall good health by facilitating the transfer of fatty acid groups into the mitochondrial membrane for cellular energy production.* It naturally occurs in red meat and other animal source foods, but we recommend supplementation to obtain optimal levels of this excellent amino acid
Resources like understanding why you are not losing weight on tirzepatide can help distinguish between medication plateaus and lifestyle factors
